{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:12:06Z","timestamp":1790860326717,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,8,6]],"date-time":"2009-08-06T00:00:00Z","timestamp":1249516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p><jats:bold>Background and purpose:\u2002<\/jats:bold>Early detection of resistance development is crucial for imatinib\u2010based treatment in chronic myeloid leukaemia (CML) patients. We aimed to distinguish metabolic markers of cell resistance to imatinib.<\/jats:p><jats:p><jats:bold>Experimental approach:\u2002<\/jats:bold>Two human imatinib\u2010sensitive CML cell lines: LAMA84\u2010s and K562\u2010s, and their resistant counterparts: LAMA84\u2010r and K562\u2010r (both resistant to 1\u2003\u00b5M imatinib), and K562\u2010R (5\u2003\u00b5M) were analysed by nuclear magnetic resonance spectroscopy to assess global metabolic profiling, including energy state, glucose and phospholipid metabolism.<\/jats:p><jats:p><jats:bold>Key results:\u2002<\/jats:bold>We found, by Western blotting and flow cytometry, that the levels of Bcr\u2010Abl tyrosine kinase and multi\u2010drug resistance p\u2010glycoprotein were inconsistent among resistant clones. On the other hand, phospholipid metabolism and lactate production were highly predictive for cell response to imatinib. As previously reported, sensitive cells showed significantly decreased glycolytic activity (lactate) and phospholipid synthesis (phosphocholine) as well as increased phospholipid catabolism (glycerophosphocholine) after 24\u2003h of 1\u2003\u00b5M imatinib treatment, which correlated with inhibition of cell proliferation and induction of apoptosis. In contrast to their sensitive counterparts, the K562\u2010r, K562\u2010R and LAMA84\u2010r maintained increased phospholipid synthesis and glycolytic lactate production in the presence of 1\u2003\u00b5M (K562\u2010r and LAMA84\u2010r) and 5\u2003\u00b5M (K562\u2010R) imatinib.<\/jats:p><jats:p><jats:bold>Conclusions and implications:\u2002<\/jats:bold>Specific metabolic markers for early detection of imatinib resistance, including increased glycolytic activity and phospholipid turnover, can be identified in resistant clones. Once validated in human isolated leukocytes, they may be used to monitor the responsiveness of CML patients to treatment.<\/jats:p>","DOI":"10.1111\/j.1476-5381.2009.00345.x","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T02:47:42Z","timestamp":1249613262000},"page":"588-600","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Metabolic characteristics of imatinib resistance in chronic myeloid leukaemia cells"],"prefix":"10.1111","volume":"158","author":[{"given":"Jelena","family":"Klawitter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J","family":"Kominsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimi L","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Klawitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Christians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Leibfritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junia V","family":"Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Gail","family":"Eckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Serkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208461"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"37747","DOI":"10.1074\/jbc.M105796200","article-title":"Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells","volume":"276","author":"Boren J","year":"2001","journal-title":"J Biol Chem"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02179-7"},{"key":"e_1_2_8_5_1","first-page":"100","article-title":"Inhibition of the Abl protein\u2010tyrosine kinase in vitro and in vivo by a 2\u2010phenylaminopyrimidine derivative","volume":"56","author":"Buchdunger E","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein\u2010tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c\u2010kit and platelet\u2010derived growth factor receptors","volume":"295","author":"Buchdunger E","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.5.1758.005a41_1758_1766"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.9.3691"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.10.3343"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20758"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V101.2.690"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900078"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(02)00035-8"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.1997.0155"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.7.7.1109"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062538"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0039"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70321-1"},{"key":"e_1_2_8_20_1","first-page":"4027","article-title":"Changes of intracellular calcium, fatty acids and phospholipids during miltefosine\u2010induced apoptosis monitored by fluorescence\u2010 and 13C NMR\u2010spectroscopy","volume":"19","author":"Henke J","year":"1999","journal-title":"Anticancer Res"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-003145"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)90343-L"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0849"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2007.03.018"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1247"},{"key":"e_1_2_8_26_1","first-page":"870","article-title":"Glucose metabolism in drug\u2010sensitive and drug\u2010resistant human breast cancer cells monitored by magnetic resonance spectroscopy","volume":"48","author":"Lyon RC","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.3.1070"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.07.010"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1318"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209097"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07724"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.3.1014"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.2165\/00129785-200505050-00002"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00181.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4276"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2003.10.005"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-08-109330"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401661"},{"key":"e_1_2_8_40_1","first-page":"3515","article-title":"Genotoxic exposure is associated with alterations in glucose uptake and metabolism","volume":"62","author":"Zhou R","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.850"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2009.00345.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2009.00345.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:48:26Z","timestamp":1739296106000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2009.00345.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,28]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1476-5381.2009.00345.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00345.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,28]]},"assertion":[{"value":"2009-08-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}